Literature DB >> 10673396

CFU-GM-derived cells form osteoclasts at a very high efficiency.

C Menaa1, N Kurihara, G D Roodman.   

Abstract

The granulocyte-macrophage progenitor (CFU-GM) is a multipotent cell that can differentiate to osteoclasts (OCLs), macrophages, or granulocytes. However, the relative potential of CFU-GM to efficiently form OCLs is unknown. In this report we demonstrate that granulocyte-macrophage colony-forming unit (CFU-GM)-derived cells represent an easily obtainable highly purified source of human OCL precursors that form OCLs at very high efficiency (greater than 90%) when cultured with RANK ligand (RANKL), macrophage colony-stimulating factor (M-CSF), and dexamethasone. The OCLs that formed have high bone-resorbing activity and form multiple resorption lacunae per OCL on dentin slices. Similarly, murine marrow-derived CFU-GM also formed OCLs at a high efficiency (>80%) when treated with RANKL, M-CSF, and dexamethasone. In contrast, more committed macrophage colony-forming unit (CFU-M)-derived cells form few OCLs under these conditions. Copyright 2000 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10673396     DOI: 10.1006/bbrc.1999.2042

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  18 in total

1.  ATP6v0d2 deficiency increases bone mass, but does not influence ovariectomy-induced bone loss.

Authors:  Taesoo Kim; Hyunil Ha; Nacksung Kim; Eui-Soon Park; Jaerang Rho; Eun Cheol Kim; Joseph Lorenzo; Yongwon Choi; Seoung Hoon Lee
Journal:  Biochem Biophys Res Commun       Date:  2010-10-30       Impact factor: 3.575

2.  CREM deficiency in mice alters the response of bone to intermittent parathyroid hormone treatment.

Authors:  Fei Liu; Sun-Kyeong Lee; Douglas J Adams; Gloria A Gronowicz; Barbara E Kream
Journal:  Bone       Date:  2007-02-01       Impact factor: 4.398

3.  Activating transcription factor 4 regulates osteoclast differentiation in mice.

Authors:  Huiling Cao; Shibing Yu; Zhi Yao; Deborah L Galson; Yu Jiang; Xiaoyan Zhang; Jie Fan; Binfeng Lu; Youfei Guan; Min Luo; Yumei Lai; Yibei Zhu; Noriyoshi Kurihara; Kenneth Patrene; G David Roodman; Guozhi Xiao
Journal:  J Clin Invest       Date:  2010-07-12       Impact factor: 14.808

4.  TULA-2, a novel histidine phosphatase, regulates bone remodeling by modulating osteoclast function.

Authors:  Steven H Back; Naga Suresh Adapala; Mary F Barbe; Nick C Carpino; Alexander Y Tsygankov; Archana Sanjay
Journal:  Cell Mol Life Sci       Date:  2012-11-13       Impact factor: 9.261

5.  Alpha9beta1: a novel osteoclast integrin that regulates osteoclast formation and function.

Authors:  Hongwei Rao; Ganwei Lu; Hiroshi Kajiya; Veronica Garcia-Palacios; Noriyoshi Kurihara; Judy Anderson; Ken Patrene; Dean Sheppard; Harry C Blair; Jolene J Windle; Sun Jin Choi; G David Roodman
Journal:  J Bone Miner Res       Date:  2006-10       Impact factor: 6.741

6.  Critical role of AKT protein in myeloma-induced osteoclast formation and osteolysis.

Authors:  Huiling Cao; Ke Zhu; Lugui Qiu; Shuai Li; Hanjie Niu; Mu Hao; Shengyong Yang; Zhongfang Zhao; Yumei Lai; Judith L Anderson; Jie Fan; Hee-Jeong Im; Di Chen; G David Roodman; Guozhi Xiao
Journal:  J Biol Chem       Date:  2013-09-04       Impact factor: 5.157

7.  Nmp4/CIZ suppresses the parathyroid hormone anabolic window by restricting mesenchymal stem cell and osteoprogenitor frequency.

Authors:  Yongzheng He; Paul Childress; Mark Hood; Marta Alvarez; Melissa A Kacena; Michael Hanlon; Bryce McKee; Joseph P Bidwell; Feng-Chun Yang
Journal:  Stem Cells Dev       Date:  2012-09-14       Impact factor: 3.272

Review 8.  Understanding and targeting osteoclastic activity in prostate cancer bone metastases.

Authors:  J L Sottnik; E T Keller
Journal:  Curr Mol Med       Date:  2013-05       Impact factor: 2.222

9.  Deletion of CD74, a putative MIF receptor, in mice enhances osteoclastogenesis and decreases bone mass.

Authors:  Se Hwan Mun; Hee Yeon Won; Paula Hernandez; Hector Leonardo Aguila; Sun-Kyeong Lee
Journal:  J Bone Miner Res       Date:  2013-04       Impact factor: 6.741

10.  OSTM1 bone defect reveals an intercellular hematopoietic crosstalk.

Authors:  Monica Pata; Céline Héraud; Jean Vacher
Journal:  J Biol Chem       Date:  2008-09-11       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.